January 1, 2002Circulation JournalOpen Access

Successful Immunoglobulin Treatment for Fulminant Myocarditis and Serial Analysis of Serum Thioredoxin. A Case Report.

View Full Paper

Ask AI

Bookmark

Why the study?

Does immunoglobulin treatment improve cardiac function and systemic inflammation in a patient with fulminant myocarditis?

Structured PICO

Does immunoglobulin treatment improve cardiac function and systemic inflammation in a patient with fulminant myocarditis?

Population

A 31-year-old woman with fulminant myocarditis, presenting with sustained ventricular tachycardia requiring intra-aortic balloon pumping and a percutaneous cardiopulmonary support system.

Intervention

Immunoglobulin treatment

Outcome

Improvement in cardiac function and systemic inflammation, and serial serum thioredoxin (TRX) levelssurrogate

Immunoglobulin treatment may improve cardiac function in fulminant myocarditis, and serum thioredoxin could serve as a biomarker for disease activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Hypothesis-generating for IVIG in fulminant myocarditis; leaves open thioredoxin as disease activity biomarker.

Cite This Study

Shioji et al. (2002) studied this question.

synapsesocial.com/papers/6a84008284161f555bc51c7f https://doi.org/10.1253/circj.66.977

Topics

Ventricular arrhythmias Myocarditis

View Full Paper

Ask AI

Bookmark

Successful Immunoglobulin Treatment for Fulminant Myocarditis and Serial Analysis of Serum Thioredoxin. A Case Report.

Structured PICO

Discussion

Implication

Cite This Study

Topics

Successful Immunoglobulin Treatment for Fulminant Myocarditis and Serial Analysis of Serum Thioredoxin. A Case Report.

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider